Nicotine and other nAChR agonists found in cigarette smoke are known to enhance Bcl-2 and Mcl-1 phosphorylation in lung cancer cell lines62–64, as well as reduce ubiquitin-dependent Bcl-2 degradation65, resulting in enhanced chemotherapeutic resistance. Here, MCL1 is linked to lung cancer.